Valuation: Alcon

Market Cap 35.35B 30.34B 28.48B 26.01B 49.09B 3,372B 49.33B 337B 131B 1,701B 133B 130B 5,634B P/E 2026 *
43.8x
P/E 2027 * 26.6x
Enterprise Value 37.9B 32.53B 30.53B 27.88B 52.62B 3,615B 52.88B 361B 140B 1,824B 142B 139B 6,040B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.13x
Free-Float
97.34%
Yield 2026 *
0.5%
Yield 2027 * 0.56%
Manager TitleAgeSince
Chief Executive Officer 60 30/06/2018
Director of Finance/CFO 58 07/04/2019
Chief Tech/Sci/R&D Officer - 31/12/2024
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 30/06/2018
Director/Board Member 63 31/01/2019
Change 5-day change 1-year change 3-year change Capi.($)
+20.17%0.00% - - 35.35B
+0.03%-2.60%-40.13%-9.61% 85.36B
-0.20%-1.31%-10.21%-20.98% 35.35B
-0.72%-5.45%-1.51%-22.27% 14.25B
-1.34%+1.18% - - 11.96B
-0.76%+9.74%-10.58%+743.48% 2.78B
+2.33%-2.66%-42.86%-56.92% 1.46B
+1.78%+3.04%+16.95%+10.70% 897M
-0.58%-1.30%+51.48%-8.18% 890M
-2.14%-4.48% - - 890M
Average -0.15%+1.03%-5.26%+90.89% 17.09B
Weighted average by Cap. -0.14%-1.61%-27.23%+0.74%

Financials

2026 *2027 *
Net sales 11.09B 9.52B 8.93B 8.16B 15.4B 1,058B 15.47B 106B 40.97B 534B 41.64B 40.73B 1,767B 11.77B 10.11B 9.48B 8.66B 16.35B 1,123B 16.43B 112B 43.5B 567B 44.21B 43.25B 1,876B
Net income 764M 656M 616M 562M 1.06B 72.89B 1.07B 7.29B 2.82B 36.77B 2.87B 2.81B 122B 1.26B 1.08B 1.01B 926M 1.75B 120B 1.76B 12B 4.65B 60.58B 4.73B 4.62B 201B
Net Debt 2.54B 2.18B 2.05B 1.87B 3.53B 243B 3.55B 24.26B 9.4B 122B 9.56B 9.35B 406B 1.45B 1.24B 1.17B 1.07B 2.01B 138B 2.02B 13.82B 5.36B 69.77B 5.44B 5.33B 231B
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA